Ocular Therapeutix, Inc. (OCUL)
9.965
-0.02
(-0.25%)
USD |
NASDAQ |
Sep 21, 16:00
10.00
+0.04
(+0.35%)
After-Hours: 20:00
Ocular Therapeutix Total Return Price : 9.965 for Sept. 21, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| September 18, 2026 | 9.99 |
| September 17, 2026 | 10.14 |
| September 16, 2026 | 9.87 |
| September 15, 2026 | 10.19 |
| September 14, 2026 | 10.72 |
| September 11, 2026 | 10.49 |
| September 10, 2026 | 10.62 |
| September 09, 2026 | 11.47 |
| September 08, 2026 | 11.37 |
| September 04, 2026 | 10.64 |
| September 03, 2026 | 10.64 |
| September 02, 2026 | 10.90 |
| September 01, 2026 | 10.57 |
| August 31, 2026 | 10.49 |
| August 28, 2026 | 10.36 |
| August 27, 2026 | 10.82 |
| August 26, 2026 | 10.77 |
| August 25, 2026 | 10.88 |
| August 24, 2026 | 10.78 |
| August 21, 2026 | 11.08 |
| August 20, 2026 | 11.09 |
| August 19, 2026 | 11.73 |
| August 18, 2026 | 11.01 |
| August 17, 2026 | 10.65 |
| August 14, 2026 | 10.04 |
| Date | Value |
|---|---|
| August 13, 2026 | 10.10 |
| August 12, 2026 | 10.23 |
| August 11, 2026 | 9.76 |
| August 10, 2026 | 9.24 |
| August 07, 2026 | 9.19 |
| August 06, 2026 | 8.74 |
| August 05, 2026 | 8.50 |
| August 04, 2026 | 8.59 |
| August 03, 2026 | 8.40 |
| July 31, 2026 | 8.17 |
| July 30, 2026 | 8.47 |
| July 29, 2026 | 8.36 |
| July 28, 2026 | 8.45 |
| July 27, 2026 | 8.64 |
| July 24, 2026 | 8.505 |
| July 23, 2026 | 8.62 |
| July 22, 2026 | 8.585 |
| July 21, 2026 | 8.93 |
| July 20, 2026 | 8.71 |
| July 17, 2026 | 8.97 |
| July 16, 2026 | 9.165 |
| July 15, 2026 | 9.96 |
| July 14, 2026 | 9.70 |
| July 13, 2026 | 9.88 |
| July 10, 2026 | 10.20 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| EyePoint, Inc. | 4.02 |
| Theravance Biopharma, Inc. | 17.05 |
| LENZ Therapeutics, Inc. | 4.07 |
| ANI Pharmaceuticals, Inc. | 78.84 |
| Corcept Therapeutics, Inc. | 113.66 |